Skip to content

Opioid Sparing Intrathecal versus Epidural Analgesia in Abdominal Cancer Surgery.

Spinal Dexmedetomidine Versus epidural Dexmedetomidine Added to bupivacaine for Prevention Pain in Patients Undergoing Open Abdominal cancer surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202409817876605
Enrollment
100
Registered
2024-09-06
Start date
2024-03-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

epidural

Sponsors

Prof.Dr. Hatem Saber
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients of both sexes American Society of Anesthesiologists (ASA) physical status I – II Aged from 35 - 65 years

Exclusion criteria

Exclusion criteria: Patients who had any contraindications to spinal or epidural anaesthesia ( Infection at the site of insertion, Spine surgery or deformity at injury level, thrombocytopenia, coagulopathy) Refusing spinal or epidural anesthesia Psychotic or difficult communication Allergy to dexmedetomidine or to local anesthetics Patients with decompensated renal and hepatic diseases or major respiratory disorders

Design outcomes

Primary

MeasureTime frame
First analgesic request starting from injection time .

Secondary

MeasureTime frame
1. Total postoperative analgesic requirement. 2. Intraoperative non-invasive blood pressure (NIBP) and heart rate (HR) every 30 min all over the operation time and at 1, 6, 12, 24 hours after recovery. 3. Patient’s pain score was assessed using visual analogue scale (VAS): scored from 0–10 (where 0=no pain and 10=the worst pain imaginable). 4. Postoperative side effects as bradycardia, hypotension, desaturation and vomiting incidence during recovery and 1st 24 hours. 5.Maximum block level: By Modified Bromage Score (Time frame; basal and every 2 hours for the next 6 postoperative hours after recovery) 6.Complication: • Nausea, vomiting and visceral pain. • post dural puncture headache. • Hospital stay time. • ICU admission rate

Countries

Egypt

Contacts

Public ContactMohamed Mamoun

Lecturer of Anesthesia surgical Intensive Care

mamoun445@hotmail.com+201093451597

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026